Maintenance fluid therapy in a tertiary hospital: A prevalence study;Fluidoterapia de mantenimiento administrada en un hospital terciario: estudio de prevalencia

Revista Espanola de Anestesiologia y Reanimacion

Volumn 64, Issue 6, 2017, Pages 306-312

  Una Orejon R ^a   Gisbert de la Cuadra, L ^b   Garriguez Perez D ^b   Diez Sebastian J ^a   Ureta Tolsada, M P ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Crystalloids; Hyperchloraemia; Intravenous fluids

Indexed keywords

BUFFER; CRYSTALLOID; ELECTROLYTE; GLUCOSE; ISOTONIC SOLUTION; SODIUM CHLORIDE;

ADMINISTRATION AND DOSAGE; AGED; BODY FLUID COMPARTMENT; CALORIC INTAKE; CHEMISTRY; CROSS-SECTIONAL STUDY; FEMALE; FLUID THERAPY; HOSPITAL DEPARTMENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; PHARMACOKINETICS; PROCEDURES; SOLUTION AND SOLUBILITY; TERTIARY CARE CENTER; THERAPEUTIC USE;

AGED; BODY FLUID COMPARTMENTS; BUFFERS; CROSS-SECTIONAL STUDIES; ELECTROLYTES; ENERGY INTAKE; FEMALE; FLUID THERAPY; GLUCOSE; HOSPITAL DEPARTMENTS; HUMANS; INFUSIONS, INTRAVENOUS; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; SODIUM CHLORIDE; SOLUTIONS; TERTIARY CARE CENTERS;

EID: 85012876192     PISSN: 00349356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redar.2016.12.006     Document Type: Article

References (30)

1. 1 Maxwell, M.H., Kleeman, C.R., Clinical disorders of fluids and electrolyte metabolism. 1994, McGraw-Hill, New York, 3–20.
2. 2 Guyton, A.C., Hall, J.E., Textbook of medical physiology. 2006, Elsevier Science.
3. 3 Starling, E., On the absorption from the connective tissues spaces. J Physiol. 19 (1986), 312–326.
4. 4 Luft, J.H., Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed Proc. 25 (1966), 1773–1783.
5. 5 Saladin, K.S., Anatomy & physiology: The unity of form and function. 5th ed., 2010, McGraw Hill, 94–95.
6. 6 Chappel, D., Jacob, M., Hofmann-Kiefer, K., Conzen, P., Rehm, M., A rational approach to perioperative fluid management. Anesthesiology. 10 (2008), 723–740.
7. 7 Shaw, A.D., Bagshaw, S.M., Goldstein, S.L., Scherer, L.A., Duan, M., Schermer, C.R., et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg. 255 (2012), 821–829.
8. 8 Chowdhury, A.H., Cox, E.F., Francis, S.T., Lobo, D.N., A randomized, controlled, double-blind crossover study on the effects of 2-L infusion of 0.9% saline and Plasma-Lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 256 (2012), 18–24.
9. 9 Myburgh, J.A., Mythen, M.G., Resuscitation fluids. N Engl J Med. 369 (2013), 1243–1251.
10. 10 Kragelund, E., Changes of the apparent 3HOH, 82Br, 125I human albumin and 51Cr red blood cell dilution volumes before, during and after operation in human subjects. Ann Surg. 172 (1970), 116–124.
11. 11 Bellomo, R., Bion, J., Finfer, S., Myburgh, J., Perner, A., Reinhart, K., Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth. 112 (2014), 595–600.
12. 12 Reddy, S., Weinberg, L., Young, P., Crystalloids fluid therapy. Crit Care., 20, 2016, 59.
13. 13 Perner, A., Haase, N., Guttormsen, A.B., Tenhunen, J., Klemenzson, G., Åneman, A.N., Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis (6S). N Engl J Med. 367 (2012), 124–134.
14. a ed., 2009 USA.
15. 15 McFarlane, C., Lee, A., A comparison of Plasmalyte 148 and 0,9% saline for intra-operative fluid replacement. Anaesthesia. 49 (1994), 779–781.
16. 16 Williams, E.L., Hildebrand, K.L., McCormick, S.A., Bedel, M.J., Effect of intravenous lactated Ringerʼs solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg. 88 (1999), 999–1003.
17. 17 Young, J.B., Utter, G.H., Schermer, C.R., Galante, J.M., Phan, H.H., Yang, Y., et al. Saline versus Plasma-Lyte in initial resuscitation of trauma patients: A randomized trial. Ann Surg. 259 (2014), 255–262.
18. 18 Hadimioglu, N., Saadawy, I., Saglqan, T., Ertug, Z., Dinckhan, A., The effect of different crystalloid solutions on acid-base balance and early kidney function after kidney transplantation. Anesth Analg. 107 (2008), 264–269.
19. 19 Young, P., Balley, M., Beasley, R., Henderson, S., Mackle, D., McArthur, C., Effect of a buffered crystaloids solutions versus saline on acute injury among patient in the intensive care unit: The SPLIT randomized clinical trial. JAMA. 314 (2015), 1701–1710.
20. 20 Kellum, J.A., Shaw, A.D., Assessing toxicity of intravenous crystalloids in critically ill patients. JAMA. 314 (2015), 1695–1697.
21. 21 Rose, B.D., Post, T.W., Trastornos de los electrolitos y del equilibrio ácido-base. 2002, Marban, Madrid, 258–286.
22. 22 Simma, B., Burger, R., Falk, M., Sacher, P., Fanconi, S., A prospective, randomized, and controlled study of fluid management in children with severe head injury: Lactated Ringer's solution versus hypertonic saline. Crit Care Med. 26 (1998), 1265–1270.
23. 23 Shackford, S.R., Bourguignon, P.R., Wald, S.L., Rogers, F.B., Osler, T.M., Clark, D.E., Hypertonic saline resuscitation of patients with head injury: A prospective, randomized clinical trial. J Trauma. 44 (1998), 50–58.
24. 24 Kempthorne, P.M., The European Consensus Statement on intraoperative fluid therapy in children: A step in the right direction. Eur J Anaesthesiol. 28 (2011), 618–619.
25. 25 Wagner, B.K., D'Amelio, L.F., Pharmacologic and clinical considerations in selecting crystalloid, colloid and oxygen arraying resuscitation fluid. Clin Pharm. 12 (1993), 335–346.
26. 26 Garnacho-Montero, J., Fernández-Mondéjar, E., Ferrer-Rocac, R., Herrera-Gutiérrez, M.E., Lorentef, J.A., Ruiz-Santanai, S., et al. Cristaloides y coloides en la reanimación del paciente crítico. Med Intensiva. 39 (2015), 303–315.
27. 27 Murney, P., To mix or not to mix-compatibilities of parenteral drug solutions. Aust Prescr. 31 (2008), 98–101.
28. 28 Schrander-vd Meer, A.M., teer Wee, P.M., Kan, G., Donker, A.J., van Dorp, W.T., Improved cardiovascular variables during acetate free biofiltration. Clin Nephrol. 51 (1999), 304–309.
29. 29 Akanji, A.O., Bruce, M.A., Frayn, K.N., Effect of acetate infusion on energy expenditure and substrate oxidation rates in non- diabetic and diabetic subject. Eur J Clin Nutr. 43 (1989), 107–115.
30. 30 Quindós, G., Eraso, E., López Soria, L., Ezpeleta, G., Enfermedad fúngica invasora: ¿diagnóstico micológico convencional o molecular?. Enfer Infecc Microbiol Clin. 30 (2012), 560–571.